Literature DB >> 27895811

Radionuclides.

Anil Kapoor1, Sebastien J Hotte2.   

Abstract

Year:  2016        PMID: 27895811      PMCID: PMC5120983          DOI: 10.5489/cuaj.4056

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  2 in total

1.  Alpha emitter radium-223 and survival in metastatic prostate cancer.

Authors:  C Parker; S Nilsson; D Heinrich; S I Helle; J M O'Sullivan; S D Fosså; A Chodacki; P Wiechno; J Logue; M Seke; A Widmark; D C Johannessen; P Hoskin; D Bottomley; N D James; A Solberg; I Syndikus; J Kliment; S Wedel; S Boehmer; M Dall'Oglio; L Franzén; R Coleman; N J Vogelzang; C G O'Bryan-Tear; K Staudacher; J Garcia-Vargas; M Shan; Ø S Bruland; O Sartor
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

2.  Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Authors:  Oliver Sartor; Robert Coleman; Sten Nilsson; Daniel Heinrich; Svein I Helle; Joe M O'Sullivan; Sophie D Fosså; Aleš Chodacki; Paweł Wiechno; John Logue; Anders Widmark; Dag Clement Johannessen; Peter Hoskin; Nicholas D James; Arne Solberg; Isabel Syndikus; Nicholas J Vogelzang; C Gillies O'Bryan-Tear; Minghua Shan; Øyvind S Bruland; Christopher Parker
Journal:  Lancet Oncol       Date:  2014-05-13       Impact factor: 41.316

  2 in total
  1 in total

1.  Correction in supplement data.

Authors: 
Journal:  Can Urol Assoc J       Date:  2016-09-13       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.